Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.

Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.

Item
http://www.wikidata.org/entity/Q33743728
A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplantationHigh-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II studyShould we continue to study high-dose chemotherapy in metastatic breast cancer patients? A critical review of the published data.Outcomes of high-dose chemotherapy and autologous stem cell transplant in isolated locally recurrent breast cancer: a multicenter evaluation.Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.Obesity is an independent predictor of poor survival in metastatic breast cancer: retrospective analysis of a patient cohort whose treatment included high-dose chemotherapy and autologous stem cell support.Maintenance hormonal treatment improves progression free survival after a first line chemotherapy in patients with metastatic breast cancerCD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.Expression of high-mobility-group-protein HMGI-C mRNA in the peripheral blood is an independent poor prognostic indicator for survival in metastatic breast cancerHigh-dose chemotherapy of cyclophosphamide, thiotepa, and carboplatin (CTCb) followed by autologous stem-cell transplantation for metastatic breast cancer patients: a 6-year follow-up result.Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits.A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531.Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer.Factors affecting progression-free survival in hormone-dependent metastatic breast cancer patients receiving high-dose chemotherapy and hematopoietic progenitor cell transplantation: role of maintenance endocrine therapy.Initially metastatic breast carcinoma has a distinct disease pattern but an equivalent outcome compared with recurrent metastatic breast carcinoma.Adjuvant anthracycline therapy as a prognostic factor in metastatic breast cancer.
P2860

Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support.

Item
http://www.wikidata.org/entity/Q33743728
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Prognostic and predictive fact ...... autologous stem-cell support.
@ast
Prognostic and predictive fact ...... autologous stem-cell support.
@en
type
label
Prognostic and predictive fact ...... autologous stem-cell support.
@ast
Prognostic and predictive fact ...... autologous stem-cell support.
@en
prefLabel
Prognostic and predictive fact ...... autologous stem-cell support.
@ast
Prognostic and predictive fact ...... autologous stem-cell support.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Prognostic and predictive fact ...... autologous stem-cell support.
@en
P2093
P304
P31
P356
10.1200/JCO.1999.17.10.3064
P407
P433
P478
P577
P698
P921